A critical breakthrough in cancer investigation is arising with the use of VHH fragments to restore mutated p53. This vital cancer inhibitor protein is frequently disabled in many forms of tumors, causing uncontrolled https://get-social-now.com/story7423613/mini-antibodies-reactivate-tumor-suppressor-p53-a-potential-hope-for-malignant-management